SCHEMBL22553767

SCHEMBL22553767

Cn1cc(-c2cnc(N)c(-c3ccc(N4CCCC4=O)cc3)c2)c2cnn(C)c2c1=O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.46
BRDT Q58F21 1/20 0.46
PIP4K2A P48426 1/20 0.45
SYK P43405 6/20 0.39
MAP4K4 O95819 1/20 0.38
FYN P06241 1/20 0.38
CCNC P24863 3/20 0.38
CDK8 P49336 3/20 0.38
LRRK2 Q5S007 2/20 0.37
TGFBR1 P36897 1/20 0.37
F10 P00742 1/20 0.37
PRSS1 P07477 1/20 0.37
PRSS2 P07478 1/20 0.37
PRSS3 P35030 1/20 0.37
NPC1 O15118 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30730859 1.00 BRD4 (0.46) BRD4BRDTPIP4K2ASYKMAP4K4
SCHEMBL22554263 0.89 PIP4K2A (0.41) BRD4BRDTPIP4K2ASYKMAP4K4
SCHEMBL30730829 0.89 PIP4K2A (0.41) BRD4BRDTPIP4K2ASYKMAP4K4
SCHEMBL22553979 0.86 BRD4 (0.48) BRD4BRDTPIP4K2ASYKCCNC
SCHEMBL22553845 0.85 AXL (0.42) PIP4K2A
SCHEMBL22554034 0.82 BRD4 (0.44) BRD4BRDTPIP4K2ASYKMAP4K4
SCHEMBL22553737 0.81 BRD4 (0.48) BRD4BRDTPIP4K2ASYKMAP4K4
SCHEMBL22554116 0.79 BRD4 (0.39) BRD4BRDTPIP4K2ASYKMAP4K4
SCHEMBL22553977 0.74 PIP4K2A (0.40) BRD4BRDTPIP4K2ASYKCCNC
SCHEMBL22553850 0.73 CHEK2 (0.54) MAP4K4FYNTGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US claimed
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2024-03-05 US disclosed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US disclosed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS PIP5K1A, PIP5K1B, PIP5K1C BRD4 309/4885BRDT 786/4885PIP4K2A 4/4885
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors PIP5K1A, PIP5K1B, PIP5K1C BRD4 309/4885BRDT 786/4885PIP4K2A 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.